Navigation Links
Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
Date:1/7/2008

Ortho-McNeil to Continue Investigation of GDIR Agonists Under its

Partnership with Arena

SAN DIEGO, Jan. 7 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that initial clinical study results for APD668, an oral drug candidate discovered by Arena and being investigated for the treatment of type 2 diabetes under a partnership with Ortho-McNeil Pharmaceutical, Inc., suggest that Glucose-Dependent Insulinotropic Receptors, or GDIRs, may improve glucose control in patients with type 2 diabetes.

Ortho-McNeil's initial clinical studies evaluated healthy volunteers and patients with type 2 diabetes in randomized, double-blind, placebo-controlled trials evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple (14 day) escalating doses of APD668. Based on the data from those studies, Ortho-McNeil has decided to put APD668 on hold and has advanced a potentially more potent Arena discovered GDIR agonist into preclinical development.

"We are encouraged by the clinical study results supporting GDIR agonists as effective modulators of glucose homeostasis in patients with type 2 diabetes, and we look forward to the results of Ortho-McNeil advancing another of Arena's GDIR compounds into development," stated Dominic P. Behan, Ph.D., Arena's Senior Vice President and Chief Scientific Officer.

About the Glucose-Dependent Insulinotropic Receptor (GDIR)

The GDIR is an orphan G protein-coupled receptor, or GPCR, discovered by Arena. It is expressed in beta cells, the cells in the pancreas responsible for producing insulin in response to increases in blood glucose. Stimulation of the GDIR is intended to more efficiently
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
2. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
3. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
4. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
5. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
6. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
7. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
8. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
9. QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
10. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
11. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)... Showed Larazotide Acetate Prevented Immunologic C...ts with Celiac Disease, Additional Data Indicates ... ORLANDO, Fla., Oct. 7 /- Alba Therap...ical studies this week at the American,College of ...ing. Data from,study CLIN 1001-004, the first Phas...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Scientific ...tCall/ -- Ironwood,Pharmaceuticals, Inc. (formerly...SE: FRX ) today announced the presentation of res... safety and efficacy in 420 patients with,irritabl...is of the data,indicates that once- daily oral dos...
(Date:10/7/2008)...ient, Prospective Randomized Placebo-Controlled Ph...ant Improved Overall Survival., MOUNTAIN VIEW, Ca...peutics has now evaluated the mature Phase II data...idate PROSTVAC(TM) that had been,obtained as part ...nal,Cancer Institute (NCI) in the US., The result...
(Date:10/7/2008)...STGÃ…RD, Denmark, October 7 /PRNewswire-FirstCall/...o-Controlled Phase II Study,Shows Statistically Si...dic has now evaluated the mature phase II data fro...e PROSTVAC(TM) that had been,obtained as part of t...Cancer Institute (NCI) in the US., The results fr...
Breaking Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5NIST announces 56 new awards for innovative technology research and development 604 1iCAD to Present at William Blair 26 Company Small Cap Growth Stock Conference 2321 1iCAD to Present at William Blair 26 Company Small Cap Growth Stock Conference 2321 2President Bush Should Protect Kids Not Big Tobacco By Signing Bill to Increase Cigarette Tax Fund SCHIP 2318 1President Bush Should Protect Kids Not Big Tobacco By Signing Bill to Increase Cigarette Tax Fund SCHIP 2318 2Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals 932 1Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals 932 2
(Date:10/7/2008)...ltrasound similar to more expensive whole-leg colo...AY, Oct. 7 (HealthDay News) -- An older, simpler t...eep vein thrombosis, or DVT -- is as effective as ..., European researchers found that 2-point ultras...on or duplex ultrasound -- was as good at detectin...
(Date:10/7/2008)...riz., Oct. 7 /PRNewswire/ -- Join Mii amo, a desti...elebration in Sedona,s red rock,country honoring t...ude a,series of traditional Native American ceremo...or R.J. Joseph and special guest, Elder George,Goo...oot Elder from the Blood Reserve,in Standoff, Albe...
(Date:10/7/2008)... 100,000 PEOPLE ACROSS THE NATION HAVE SAID ,I VOT... DALLAS, Oct. 7 /PRNewswire/ -- To aid and help e...out the positions of presidential candidates,Senat...e and cancer issues,the Susan G. Komen for the Cu... resources available on its web site --, http://ww...
(Date:10/7/2008)...N, Oct. 7 /PRNewswire-USNewswire/ -- The Catholic ...n conjunction with Catholic,Health Initiatives (CH...;,and Trinity Health, Novi, MI -- is launching a m...l climate change., Through receipt of a $20,000 g...he Environment (NRPE) and the Catholic Coalition o...
Breaking Medicine News(10 mins):Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3Health News:Mii amo Honors Winter Solstice With Traditional Native American Celebration December 18-21 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3Health News:Catholic Health Organizations Launch Ministry-Wide Effort to Raise Awareness About Global Climate Change 2
...sts have developed a scan that could spot the earl...ated illness.// The new machine, which uses techno...of liver damage drinkers may be doing themselves, ...n of Daily Mail. Until now damage could be accurat...
...ing fatty dairy products may actually help in slim... specialists have cautioned people to be wary of s...nvolved in this study. At the end of this study, i...fat free milk had put on more weight when compared...
...re many agencies which are involved in different k...research findings. Each agency may come out with d...the funding agency. In this connection, Dr. David...nd Harvard University says that there are numerous...
...ampsia, an extremely undesirable condition in preg...and child. The condition is said to claim the live...scientists have devised a new diagnostic evaluatio...cting the condition early and saving lives. The r...
Other Medicine News:
...Intermec has an installed base of field-proven bar...spital departments using Intermec media include; r...y, Admissions, Nursing Stations, Pharmacy, Medical...ing materials includes many products that are fitt...
...MediCopia is a system for inpatient caregiving tha...a's automated computer system offers four technolo...are a handheld computer (for work order processing...cation), thermal printer (for label generation at ...
For superior bar code scanning performance with maximum user comfort at a highly attractive price, the LS 4000i Scanner Series from Symbol Technologies establishes an award-winning standard of excell
The IMAGETEAM 4600 SR / SF area imager from Hand Held Products combines the versatility of area imaging with the speed and cost of linear scanning for healthcare, retail and commercial applications.
Medicine Products: